Viewing Study NCT05694260


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2025-12-26 @ 3:19 AM
Study NCT ID: NCT05694260
Status: COMPLETED
Last Update Posted: 2025-08-08
First Post: 2023-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1)
Sponsor: Esperion Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module